{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"From Gene to Lipid to Clinic: The Rise of RNA Therapies","description":"\ud83d\udea8 New NEJM study highlights a breakthrough in triglyceride management! \ud83e\uddec In the ESSENCE\u2013TIMI 73b trial, monthly subcutaneous olezarsen targeting APOC3 cut triglycerides by ~60% at 6 months \ud83d\udcc9\u2014with strong safety and nearly 90% reaching normal TG levels. A promising step in precision lipid therapy! \ud83d\udc89\ud83e\udec0 #Lipidology #RNAtherapeutics #Cardiology #NEJM #Olezarsen #APOC3 ","author_name":"Dr. RR Baliga's 'Podkast for the Kurious Doc'. Where Curiosity meets Clarity!","author_url":"http:\/\/www.MasterMedFacts.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/38469720\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/193833335"}